Search

Your search keyword '"Gons, Rob"' showing total 47 results

Search Constraints

Start Over You searched for: Author "Gons, Rob" Remove constraint Author: "Gons, Rob"
47 results on '"Gons, Rob"'

Search Results

1. Collateral-based selection for endovascular treatment of acute ischaemic stroke in the late window (MR CLEAN-LATE): 2-year follow-up of a phase 3, multicentre, open-label, randomised controlled trial in the Netherlands

2. Cognitive impairment in young adults following cerebellar stroke: Prevalence and longitudinal course

3. Endovascular treatment versus no endovascular treatment after 6–24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial

4. Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial

5. Impact of the lockdown on acute stroke treatments during the first surge of the COVID-19 outbreak in the Netherlands

6. Trigger factors in patients with a patent foramen ovale—associated stroke: A case-crossover study

7. Cognitive trajectory in the first year after first-ever ischaemic stroke in young adults: the ODYSSEY study.

8. Cognitive trajectory in the first year after first-ever ischaemic stroke in young adults: the ODYSSEY study

9. Endovascular treatment versus no endovascular treatment after 6–24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands:a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial

10. Risk Factors and Causes of Ischemic Stroke in 1322 Young Adults

11. Effect of Intravenous Alteplase Treatment on First-Line Stent Retriever Versus Aspiration Alone During Endovascular Treatment

12. Subacute cognitive impairment after first-ever transient ischemic attack or ischemic stroke in young adults: The ODYSSEY study

13. Trigger Factors for Stroke in Young Adults

15. Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED):an open-label, multicentre, randomised controlled trial

16. Stroke genetics informs drug discovery and risk prediction across ancestries

17. Impact of the lockdown on acute stroke treatments during the first surge of the COVID-19 outbreak in the Netherlands

18. Additional file 1 of Impact of the lockdown on acute stroke treatments during the first surge of the COVID-19 outbreak in the Netherlands

19. sj-docx-1-eso-10.1177_23969873221132032 – Supplemental material for Subacute cognitive impairment after first-ever transient ischemic attack or ischemic stroke in young adults: The ODYSSEY study

20. Subacute cognitive impairment after first-ever transient ischemic attack or ischemic stroke in young adults: The ODYSSEY study.

21. Trigger Factors for Stroke in Young Adults: A Case-Crossover Study.

22. A Randomized Trial of Intravenous Alteplase before Endovascular Treatment for Stroke

23. A randomized trial of intravenous alteplase before endovascular treatment for stroke

36. Causes and consequences of cerebral small vessel disease. The RUN DMC study: a prospective cohort study. Study rationale and protocol

37. Short-Term and Long-Term Risk of Recurrent Vascular Event by Cause After Ischemic Stroke in Young Adults.

38. Diffusion tensor imaging and cognition in cerebral small vessel disease: the RUN DMC study

39. Observational Dutch Young Symptomatic StrokE studY (ODYSSEY): study rationale and protocol of a multicentre prospective cohort study

45. Cerebral White Matter Lesions and Lacunar Infarcts Contribute to the Presence of Mild Parkinsonian Signs

46. Frontal and Temporal Microbleeds Are Related to Cognitive Function

47. Publisher Correction : Stroke genetics informs drug discovery and risk prediction across ancestries

Catalog

Books, media, physical & digital resources